Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database

BACKGROUND: Cilostazol has been associated with spontaneous reports of cardiovascular adverse events and serious bleeding. The objective of this study is to determine the relative risk of cardiovascular adverse events or haemorrhages in patients with peripheral artery disease treated with cilostazol...

Descripción completa

Detalles Bibliográficos
Autores principales: Real, Jordi, Serna, M Catalina, Giner-Soriano, Maria, Forés, Rosa, Pera, Guillem, Ribes, Esther, Alzamora, Maite, Marsal, Josep Ramon, Heras, Antonio, Morros, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941464/
https://www.ncbi.nlm.nih.gov/pubmed/29739318
http://dx.doi.org/10.1186/s12872-018-0822-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941464/
https://www.ncbi.nlm.nih.gov/pubmed/29739318
http://dx.doi.org/10.1186/s12872-018-0822-4

Ejemplares similares